BMSN. Jobrano post. $$-->>Bio-Matrix shares
Post# of 5066
Posted On: 09/12/2013 12:55:23 PM
BMSN. Jobrano post. $$-->>Bio-Matrix shares will surge this weeks/months after the biotechnology company announced that it formed a new subsidiary, Regen BioPharma Inc. And now Regen BioPharma Files Investigational New Drug (IND) Application With FDA on HemaXellerate I(TM) Stem Cell Drug for Aplastic Anemia. This is extreme huge to say.
BMSN’s new subsidiary has developed a vertically-integrated structure and is focused on acquiring patents -->>$$$, performing accelerating preclinical and clinical development and licensing or selling technology developed to large pharma companies in the area of stem cells.
Regen, to date, has reviewed issued patents $$$ covering stem cell related subject matter. The company has already created a list of 30 promising technologies for rapid commercialization and is in talks to license a number of these technologies.
David R. Koos, Chairman and CEO of Bio-Matrix Scientific Group, said that BMSN is assembling the team and capabilities to in-license and evaluate technologies rapidly, then to develop the regulator package and initiate clinical trials, and the results is coming early this year. Big FDA-play here. Also merger with 1 or 2 company is huge to say.
This paragraph is big;
"Regen BioPharma's first indication of HemaXellerate™ will be patients with aplastic anemia who are drug resistant and not eligible for bone marrow transplantation. Demonstration of efficacy in this patient population is anticipated to lead the way for entry into the $18 billion hematopoietic growth factor market which includes conditions such as anemia, thrombocytopenia, and chemotherapy associated leukopenia.
This is very good news for BMSN. This news confirms that BMSN has now been thrown into a web of very serious medical companies
Regen intends to filed an IND Application and conduct Phase I/II clinical trials during 2013 and 2014. And they did. More results coming!!
We are in play with the FDA, we gonna see pennies for sure. A lot more potential then for example ambs.
This BMSN news has subliminal major market implications that leads to think that they must have confirmation of a few major events to be announced and on their way. The news will soaked in with the market as it is showing up to hit some of the major wires. BMSN has some big testingnews coming. Expecting a big run on the shares. We gonna test the 52-week range..
BMSN.
BMSN’s new subsidiary has developed a vertically-integrated structure and is focused on acquiring patents -->>$$$, performing accelerating preclinical and clinical development and licensing or selling technology developed to large pharma companies in the area of stem cells.
Regen, to date, has reviewed issued patents $$$ covering stem cell related subject matter. The company has already created a list of 30 promising technologies for rapid commercialization and is in talks to license a number of these technologies.
David R. Koos, Chairman and CEO of Bio-Matrix Scientific Group, said that BMSN is assembling the team and capabilities to in-license and evaluate technologies rapidly, then to develop the regulator package and initiate clinical trials, and the results is coming early this year. Big FDA-play here. Also merger with 1 or 2 company is huge to say.
This paragraph is big;
"Regen BioPharma's first indication of HemaXellerate™ will be patients with aplastic anemia who are drug resistant and not eligible for bone marrow transplantation. Demonstration of efficacy in this patient population is anticipated to lead the way for entry into the $18 billion hematopoietic growth factor market which includes conditions such as anemia, thrombocytopenia, and chemotherapy associated leukopenia.
This is very good news for BMSN. This news confirms that BMSN has now been thrown into a web of very serious medical companies
Regen intends to filed an IND Application and conduct Phase I/II clinical trials during 2013 and 2014. And they did. More results coming!!
We are in play with the FDA, we gonna see pennies for sure. A lot more potential then for example ambs.
This BMSN news has subliminal major market implications that leads to think that they must have confirmation of a few major events to be announced and on their way. The news will soaked in with the market as it is showing up to hit some of the major wires. BMSN has some big testingnews coming. Expecting a big run on the shares. We gonna test the 52-week range..
BMSN.
(0)
(0)RIVULET MEDIA INC. (RIVU) Stock Research Links
Scroll down for more posts ▼